Shrinkflex (Thailand) PCL
SET:SFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shrinkflex (Thailand) PCL
SET:SFT
|
TH |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
CN |
|
Elevate Uranium Ltd
ASX:EL8
|
AU |
|
Excelsior Solutions Corp
OTC:BRYN
|
US |
|
N
|
NewGenIvf Group Ltd
NASDAQ:NIVF
|
SG |
|
Woojin Plaimm Co Ltd
KRX:049800
|
KR |
|
T
|
Tesla Exploration Ltd
OTC:TXLZF
|
CA |
Balance Sheet
Balance Sheet Decomposition
Shrinkflex (Thailand) PCL
Shrinkflex (Thailand) PCL
Balance Sheet
Shrinkflex (Thailand) PCL
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
10
|
5
|
111
|
99
|
31
|
16
|
21
|
26
|
|
| Cash Equivalents |
10
|
5
|
111
|
99
|
31
|
16
|
21
|
26
|
|
| Short-Term Investments |
0
|
0
|
150
|
71
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
82
|
101
|
150
|
170
|
168
|
205
|
204
|
199
|
|
| Accounts Receivables |
82
|
101
|
150
|
137
|
153
|
189
|
185
|
191
|
|
| Other Receivables |
0
|
0
|
0
|
33
|
15
|
16
|
19
|
8
|
|
| Inventory |
106
|
124
|
116
|
217
|
241
|
250
|
256
|
261
|
|
| Other Current Assets |
2
|
1
|
1
|
4
|
10
|
1
|
3
|
1
|
|
| Total Current Assets |
199
|
231
|
527
|
561
|
449
|
472
|
484
|
487
|
|
| PP&E Net |
150
|
182
|
302
|
372
|
582
|
613
|
659
|
612
|
|
| PP&E Gross |
0
|
0
|
0
|
372
|
582
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
259
|
313
|
0
|
0
|
0
|
|
| Intangible Assets |
5
|
5
|
5
|
5
|
5
|
5
|
4
|
4
|
|
| Other Long-Term Assets |
6
|
8
|
9
|
6
|
10
|
12
|
12
|
14
|
|
| Total Assets |
360
N/A
|
425
+18%
|
843
+98%
|
944
+12%
|
1 046
+11%
|
1 102
+5%
|
1 159
+5%
|
1 117
-4%
|
|
| Liabilities | |||||||||
| Accounts Payable |
64
|
75
|
83
|
67
|
94
|
127
|
148
|
146
|
|
| Accrued Liabilities |
0
|
0
|
0
|
26
|
19
|
0
|
0
|
0
|
|
| Short-Term Debt |
50
|
41
|
3
|
8
|
3
|
72
|
48
|
3
|
|
| Current Portion of Long-Term Debt |
13
|
22
|
23
|
22
|
23
|
31
|
52
|
54
|
|
| Other Current Liabilities |
1
|
3
|
5
|
18
|
50
|
2
|
1
|
0
|
|
| Total Current Liabilities |
129
|
141
|
115
|
140
|
189
|
233
|
248
|
203
|
|
| Long-Term Debt |
9
|
52
|
66
|
59
|
94
|
105
|
141
|
90
|
|
| Other Liabilities |
1
|
4
|
5
|
6
|
7
|
8
|
10
|
15
|
|
| Total Liabilities |
138
N/A
|
197
+42%
|
185
-6%
|
206
+11%
|
290
+41%
|
346
+19%
|
399
+15%
|
308
-23%
|
|
| Equity | |||||||||
| Common Stock |
55
|
100
|
220
|
220
|
220
|
220
|
220
|
220
|
|
| Retained Earnings |
167
|
128
|
59
|
139
|
158
|
157
|
162
|
211
|
|
| Additional Paid In Capital |
0
|
0
|
379
|
379
|
379
|
379
|
379
|
379
|
|
| Total Equity |
222
N/A
|
228
+3%
|
658
+188%
|
738
+12%
|
756
+2%
|
756
0%
|
760
+1%
|
809
+6%
|
|
| Total Liabilities & Equity |
360
N/A
|
425
+18%
|
843
+98%
|
944
+12%
|
1 046
+11%
|
1 102
+5%
|
1 159
+5%
|
1 117
-4%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
440
|
440
|
440
|
440
|
440
|
440
|
440
|
440
|
|